Charles Watts - May 21, 2024 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Director
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Charles Watts
Stock symbol
BDSX
Transactions as of
May 21, 2024
Transactions value $
$0
Form type
4
Date filed
5/23/2024, 07:15 PM
Previous filing
Apr 3, 2024
Next filing
Jul 18, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Award $0 +46.7K $0.00 46.7K May 21, 2024 Common Stock 46.7K Direct F1, F2
transaction BDSX Stock Options (Right to Buy) Award $0 +37.1K $0.00 37.1K May 21, 2024 Common Stock 37.1K $1.57 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.
F2 These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.
F3 This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.